Stryker Corporation

United States · owned by Independent (United States) · stryker.com · 34 vendors

Stryker Corporation is one of the world's leading medical technology companies, offering a broad range of innovative products and services in orthopaedics, medical and surgical, and neurotechnology and spine. The company serves healthcare professionals and patients across more than 75 countries worldwide. Stryker's products include implants, surgical equipment, neurovascular devices, and hospital beds and stretchers.

Resilience scores

Technology vendors

Insights

Last updated 2026-09-13 · revision 3

34 direct vendors, 348 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 4/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

Stryker Corporation's migration readiness assessment is severely limited by the absence of key data points. Crucially, there is no information available regarding the internal tech stack, including whether systems are cloud-native, containerized, or utilize microservices, which are fundamental indicators of migration readiness. Similarly, details on the regulatory environment and financial stability (ability to fund migration) are not provided. Regarding vendor relationships, the data presents a contradiction: 'Total Vendors: 0' is listed, yet other details indicate 'Total Services: 69' and 'Vendor HQ Countries' across 5 nations. If 'Total Vendors: 0' is accurate, it would imply no vendor lock-in, which is a significant advantage for migration. However, if the other vendor data is to be considered, the 'Vendor Lock-in Risk' is explicitly stated as 'Unknown', making it impossible to assess this critical factor. The presence of 69 services, without knowing the number of underlying vendors, also makes it difficult to gauge potential vendor concentration and associated migration complexity. 'Data Residency Requirements' are 'Not specified', which could offer flexibility but also indicates a lack of clarity that might pose challenges during migration planning. Given the extensive gaps in information, particularly concerning the internal technology landscape and the ambiguity surrounding vendor lock-in, the migration readiness score is assessed as 40. This reflects a low-to-medium readiness, primarily due to the significant unknowns that could present substantial challenges during a migration initiative.

Compliance

7 in-scope frameworks identified; showing 3.

FDA Medical Device Regulations — Assessment Required

As a medical device manufacturer operating in the US, Stryker must comply with FDA Quality System Regulation (QSR) and Medical Device Reporting (MDR) requirements. FDA violations can result in warning letters, consent decrees, product recalls, and criminal charges. Non-compliance could shut down manufacturing operations and result in hundreds of millions in losses, as seen with other medical device companies.

EU Medical Device Regulation — Assessment Required

Given Stryker's extensive EU operations evidenced by country-specific websites across multiple EU countries, they must comply with EU MDR for medical devices sold in the European market. Non-compliance can result in product recalls, market withdrawal, and significant financial penalties. The medical device industry has faced major compliance challenges with MDR implementation.

SOC 2 (source) — Assessment Required

If Stryker provides cloud-based medical device software, remote monitoring services, or SaaS solutions to healthcare providers, SOC2 compliance would be expected by customers. While not legally mandated, lack of SOC2 certification could result in loss of business opportunities and customer trust. The risk is moderate as it primarily affects business competitiveness rather than regulatory penalties.

Financials

Three-year financials

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report